e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Clearside Biomedical, Inc. - Common Stock
(NQ:
CLSD
)
4.230
-0.120 (-2.76%)
Streaming Delayed Price
Updated: 10:15 AM EDT, Oct 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clearside Biomedical, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
3 Cheap Stocks to Buy Under $1 in October 2023
October 26, 2023
If you want extreme returns and can handle the prospects of utterly devastating losses, these cheap stocks under $1 might entice.
Via
InvestorPlace
Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio
October 07, 2023
Jiangsu QYuns Therapeutics filed for a Hong Kong IPO to underwrite development of its portfolio of clinical stage biologic antibody drugs for autoimmune and allergic diseases. Meanwhile, Biogen...
Via
Talk Markets
Topics
Initial Public Offering
Clearside Biomedical And 3 Other Stocks Under $3 Insiders Are Buying
October 05, 2023
The Dow Jones closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
May 29, 2023
Via
Benzinga
What 8 Analyst Ratings Have To Say About Clearside Biomedical
May 12, 2023
Via
Benzinga
Clearside Biomedical: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
What 6 Analyst Ratings Have To Say About Clearside Biomedical
April 19, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
June 14, 2023
Via
Benzinga
Where Clearside Biomedical Stands With Analysts
April 19, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About Clearside Biomedical
March 10, 2023
Via
Benzinga
A Preview Of Clearside Biomedical's Earnings
March 08, 2023
Via
Benzinga
Analyst Expectations for Clearside Biomedical's Future
February 03, 2023
Via
Benzinga
Analyst Bumps Up Clearside Biomedical Target Price After Encouraging Trial Data
November 10, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 17, 2023
Via
Benzinga
United Airlines To Rally Around 54%? Here Are 10 Other Analyst Forecasts For Friday
March 10, 2023
Piper Sandler raised the price target for Riskified Ltd. (NYSE: RSKD) from $6 to $8. Piper Sandler analyst Brent Bracelin upgraded the stock from Neutral to Overweight. Riskified shares rose 2.4% to...
Via
Benzinga
Clearside Biomedical Touts Encouraging Durable Data From Investigational Candidate For Vision Disorder
February 02, 2023
Clearside Biomedical Inc (NASDAQ: CLSD) announced results from the Extension Study of its OASIS Phase 1/2a trial of CLS-AX (axitinib) administered by suprachoroidal injection via SCS Microinjector in...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 17, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 09, 2023
Via
Benzinga
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
November 14, 2022
Visit https://www.startengine.com/aiviva to invest in AiViva’s StartEngine Campaign.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 02, 2022
Gainers Monopar Therapeutics (NASDAQ:MNPR) shares increased by 53.0% to $4.09 during Wednesday's pre-market session. The company's market cap stands at $52.0 million.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 27, 2022
Gainers Clearside Biomedical (NASDAQ:CLSD) stock rose 27.3% to $1.35 during Thursday's pre-market session. The market value of their outstanding shares is at $81.2 million.
Via
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Clearside Biomedical Q2 Earnings
August 09, 2022
Clearside Biomedical (NASDAQ:CLSD) reported its Q2 earnings results on Tuesday, August 9, 2022. Here's what investors need to know about the announcement. Earnings Clearside Biomedical reported...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 08, 2022
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End of The Day Summary
July 26, 2022
Via
Benzinga
Clearside Biomedical Sees Initial-Stage Chronic Eye Disorder Study Results In Q4 2022
July 26, 2022
Clearside Biomedical (NASDAQ: CLSD) has completed dosing in Cohorts 3 and 4 of OASIS study of its lead drug CLS-AX (axitinib injectable suspension) in patients with neovascular age-related macular...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Facebook
Twitter
YouTube